Innate Immunity and Pathology of the Critical patient

09/03/2021

IDIBELL researchers identify three clinical profiles of patients with COVID-19 with prognostic implications

18/11/2020

Bellvitge will study the application of artificial intelligence in the treatment of Covid-19 in ICUs

08/04/2020

The health department will finance 3 IDIBELL’s projects on COVID-19

23/03/2020

An alternative drug to antibiotics receives the boost from the CaixaImpulse Consolidate program

29/05/2019

SeptiLoop receives € 100,000 to develop a rapid diagnostic kit for sepsis

13/12/2018

IDIBELL and Bellvitge University Hospital develop a new treatment to fight against hospital infections

22/10/2018

IDIBELL’s health innovation model visits Barcelona and Japan

28/05/2018

Green light to REMAB, a new IDIBELL Spin-Off

18/12/2017

A new model to overcome rejection in xenotransplantation

11/01/2016

Genetic engineering to prevent rejection in xenotransplantation

Scroll to Top